1-methyl-1H-indazole-3-carbonitrile, 95.0%, 250mg

4-amino-3-(3-methoxyphenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 500mg

2-(Methylthio)-4-(trifluoromethyl)benzoic acid, 98%, 10g

Ethyl 2-chloro-3-cyano-6-(trifluoromethyl)-pyridine-5-carboxylate, 95.0%, 1g

2-{2-[(4-Methylbenzenesulfonyl)oxy]ethoxy}ethyl 4-methylbenzene-1-sulfonate, 97%, 10g

N,N'-Bis(2,4,6-trimethoxyphenyl)oxalamide, 97%, 5g

(2E)-1-(2,4-dimethylphenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

4,8-Dichloroquinazoline, 95.0%, 10g

Colonna capillare per GC ROTI®Cap-1701, 60 m, 0,32 mm, 0,25 µm, 1 Pezzo(i)

Methyl 5-formyl-1H-pyrrole-2-carboxylate, 95.0%, 1g

(S)-2-(Aminoethyl)-1-N-Boc-pyrrolidine, 97.0%, 1g

2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-, 95%+, 100g

4-Amino-2-chloro-5-fluorobenzonitrile, 95.0%, 5g